|
MLH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.540320E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.303400E-01 |
| Normal-vs-Stage2 |
1.878990E-01 |
| Normal-vs-Stage3 |
4.009200E-04 |
| Normal-vs-Stage4 |
7.895100E-03 |
| Stage1-vs-Stage2 |
4.769600E-01 |
| Stage1-vs-Stage3 |
1.581200E-03 |
| Stage1-vs-Stage4 |
2.599600E-02 |
| Stage2-vs-Stage3 |
2.024200E-01 |
| Stage2-vs-Stage4 |
3.100000E-01 |
| Stage3-vs-Stage4 |
9.626000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.416200E-03 |
| Normal-vs-AfricanAmerican |
3.832600E-01 |
| Normal-vs-Asian |
1.685970E-01 |
| Caucasian-vs-AfricanAmerican |
3.955800E-01 |
| Caucasian-vs-Asian |
8.429900E-02 |
| AfricanAmerican-vs-Asian |
1.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.663700E-03 |
| Normal-vs-Female |
1.108200E-01 |
| Male-vs-Female |
3.602600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.779380E-01 |
| Normal-vs-Age(41-60Yrs) |
3.016600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.256600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.254300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.337800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.924000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.289200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.367800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.901820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.545000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.176200E-03 |
| Normal-vs-Grade 2 |
7.132400E-01 |
| Normal-vs-Grade 3 |
8.601000E-04 |
| Normal-vs-Grade 4 |
1.165260E-04 |
| Grade 1-vs-Grade 2 |
1.076500E-02 |
| Grade 1-vs-Grade 3 |
2.04500000000607E-06 |
| Grade 1-vs-Grade 4 |
7.74440000000931E-05 |
| Grade 2-vs-Grade 3 |
3.631700E-04 |
| Grade 2-vs-Grade 4 |
9.50100000000065E-05 |
| Grade 3-vs-Grade 4 |
8.516300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.413000E-01 |
| Normal-vs-ccB subtype |
8.0789000000081E-05 |
| ccA subtype-vs-ccB subtype |
7.32379999979216E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.014000E-01 |
| Normal-vs-N1 |
6.26959999999732E-05 |
| N0-vs-N1 |
4.597300E-04 |
|
|
